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ABSTRACT
PRESCRIPTION DESIGN FOR THE IMPAIRED
Amber Kleitz
May 2018
This thesis is a critical analysis of the state 
of prescription drug packaging in the United States 
with respect to unresolved problems for users with 
visual, physical, and cognitive impairments. It begins 
with an anecdotal overview inspired by Deborah Adler’s 
journey of prescription drug packaging for her 
grandparents and her design solution outlined by a 
case study. This case study focuses on the need for 
better prescription packaging for those with the 
aforementioned and neglected issues.
This thesis uses studies in user-centered design, 
packaging design, and industrial design among others 
in order to critically assess and question the current 
state of user experience for those with impairments. 
The latter part of the thesis argues that a 
universal standard would be difficult to implement due 




Figure 1. Clear RX Packaging Concept designed and developed 
by Deborah Adler in partnership with Andrew Koch and Target 
Pharmacy
Image from Adler Design
Figure 2. “Inclusive Pill Bottles for the Blind” Packaging 
Design system Concept by Alex Broerman and Ashley Ma at the 
University of Cincinnati, 2012
Image from Ma’s Portfolio site
Figure 3. Filson Soft f-ligatures with optimal kerning and 
0 tracking.
Figure 4. Myriad Pro f-ligatures with optimal kerning and 0 
tracking.
Figure 5. Aleve® Easy Open Soft Grip Arthritis Cap;
Image from arthritis.org
Figure 6. 1-Click Packaging System by Centor;
Image from arthritis.org
Figure 7. Medication packaging, industrial, and product 
design by Christine Chau
Image from Behance
Figure 8. Table data and images of MMDs: the Dossett, the 
nomad Clear, and the Venalink. Font sizes summarized below 
their respective image.
Table and Images from Adams, 2013
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Figure 9. MedReady MMD by MedReady, Inc.
Top-Down view shows the patient perspective, an open 
compartment and time display on lid.
Image from MedReady, Inc.  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INTRODUCTION
One of the most essential parts of growing old is 
maintaining a healthy body. As natural decline creeps in on 
daily life, routine visits to a physician and careful 
attention to prescribed drugs become increasingly important 
and sometimes the central focus in life. The misuse of 
taking the necessary prescription medication to live a 
healthy life is a problem adults over the age of 65 in the 
United States face. Sadly, this is due to problems of a 
long history of poorly and inconsistently designed 
prescription packaging. For those who prefer to live 
independently from any home-care, assisted living, or 
family members, things that used to be simple suddenly 
become risks. 
This thesis will address the main factors that affect 
the efficiency of a prescription design including, but not 
limited to, visual, physical, and cognitive impairment. All 
three of these factors currently affect adults in the 
United States. Adults over the age of 65 count for 30% of 
the United States pharmaceutical expenditures, although 
they only account for 13% of the total population. By 
researching the problems this population faces. Products 
that have hit the market in attempt to resolve these 
problems and I hope to propose a robust solution that may 
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be tested by pharmaceutical companies. A viable solution 
could lead to a national standard policy.
I am not the first to assume this is possible. In 
fact, another designer was faced with the same familial 
experience for her work with Target Pharmacy, Clear Rx. 
This case study was inspired by her grandparents taking 
each others’ medicine by mistake. With the same first 
initial and last name and a similar looking bottle, the 
label was rendered useless if given little attention. This 
designer, Deborah Adler, created a system for her 
grandparents to quickly identify whose medicine they were 
looking for by simple use of a colored band around the top. 
In addition, she was able to address further concerns of 
the hierarchy of most necessary information and custom made 
iconography that lessened the need for phrases that would 
otherwise take up valuable space on such a small surface. 
Despite the great design success that Clear Rx was, 
Adler wasn’t finished. Adler Design partnered with CVS 
Pharmacy to recreate a new system for labeling the classic 
amber-colored pill bottles. This new labeling system 
features daily routine instructions by using a simple table 
utilizing color and iconography. Because this label did not 
need to change the physical design of the bottle, it was 
much easier for the large pharmaceutical company to adopt 
than if they had to change the physical production of the 
bottle itself. 
"2
Of these two case studies that will be explored later 
on, they address different inhibitors separately and 
without relation to another. Clearly there is no one-fix 
solution for all – at least not at this point in time. The 
goal is to evaluate what we know about the most common 
inhibitors of accurate prescription handling and theorize 
what we are currently able to test. If there is a solution 
or a system of small solutions that would be easy to adopt, 
the user experience of a daily routine could be seamless 
with as little mental pain points as possible. 
 There will be three outlined directions to address 
the issues I stated. The first concern is that of the most 
common visual impairments including refractive errors, 
cataract, glaucoma, diabetic retinopathy, and macular 
degeneration. The second concern will address physical 
impairments such as arthritis, limited dexterity of hands, 
carpal tunnel, cerebral palsy, and multiple sclerosis. The 
last impairment to be addressed is that of a cognitive 
nature. This impairment is too vast to address all aspects 
in focus, so I will only address the conditions in the 
stages before the patient is no longer able to 
independently perform daily activities. These conditions 
include types of amnesic and non-amnesic Memory Cognitive 




The most commonly addressed problem in pharmaceutical 
packaging and the design community is visual impairment. 
Age-related vision loss is very common, and is responsible 
for a large amount of responsibility as a cause of medicine 
mis-adherence. Most common types of impairment include 
refractive errors such as near-sightedness, far-
sightedness, and the like. These cases account for 42% of 
the total number of reported visual impairment cases. 
Following refractive errors, impairments such as cataracts, 
glaucoma, age-related macular degeneration (AMD), and 
diabetic retinopathy also cause a serious risk for mis-
adherence. 
Symptoms of blurry or patchy vision and clouding of 
the lens make it very difficult for a patient to read any 
words on a label. This label contains vital information 
that a patient needs to know to decrease risk or harm to 
themselves. The name of the patient, the prescription name, 
and the instructions are the most important parts of the 
label and if misread, the prescription is useless. There 
are solutions that are already being implemented or tested 
to address a number of these issues.
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COLOR
The first and most obvious solution would be the use 
of color. In a study with a population of 126 glaucoma 
patients, 65% claimed to use color as a way of organizing 
their medication (Brandt, 2015). 
There are traditionally three main elements of a pill 
bottle that color can intentionally be used to mark special 
attributes to the medication - the cap, label, and bottle 
walls. Warning stickers also serve a purpose with colors 
that are meant to grab attention, like orange cautionary 
labels. Unfortunately, the color of the label blends in 
with the current standard amber bottles and a sticker added 
post-printing may obstruct important information for the 
patient. 
A solution called Clear RX implemented colored rings 
helped to identify ownership in a multi-person household. 
The patient chooses one of six colors to be included on the 
neck of a bottle as a ring or as a sticker on a 
prescription that does not utilize a bottle design. This 
project was conceived by Deborah Adler for her masters 
thesis in collaboration with an industrial designer, Andrew 
Koch. There was significant research and user testing that 
went into this project as the patents are iterative and 
reveal much of the reasoning behind the design. However, 
there are a number of problems with resorting to only 
changing the color of the cap or ring of a medication. 
There are multiple approaches in the use of color on a 
"5
prescription bottle including time of day to take it, who 
the medication is for, and the type of medication. 
Different methods of color usage on a package make the 
system unreliable and creates inherent risk for patients. 
Many older adults take more than one type of 
medication and the possibility of switching a cap is 
alarmingly common. Doctors can not trust that patients will 
always remember to only open one prescription at a time or 
to check labels in addition to the color, let alone know 
the correct spelling of the medication. In a study 
involving 102 participants of both doctors and patients, 
overall agreement on a color name was very poor. Four 
particular medications on a blue-green spectrum had less 
the 15% agreement rate. (Pujan, 2015)
Color blindness is a condition most common in males 
and has been linked to heredity. There are different 
spectrums of color blindness such as red-green and blue-
yellow (National Eye Institute, 2015). 
Glaucoma is a condition that increases in severity as 
time goes on, dulling and distorting colors. Eventually a 
color system will be rendered uses to these kinds of 
patients. Seeing as how there is no cure for glaucoma, 




FIGURE 1. CLEAR RX PACKAGING CONCEPT DESIGNED AND 
DEVELOPED BY DEBORAH ADLER IN PARTNERSHIP WITH 
ANDREW KOCH AND TARGET PHARMACY
IMAGE FROM ADLER DESIGN
PATTERN & TEXTURE
A second solution involves the use of pattern and 
possibly texture. In addition to color, the use of pattern 
can supplement quick recognition of specific medications. 
For those that are unable to accurately read words without 
assistance especially in the cases of close-proximity, the 
use of a simple pattern would differentiate even for color-
blind patients. The use of only triangles, squares, and 
circles might not be enough for patients that have more 
than three medications or three others in the household. 
However, the composition or repetition in a space would 
provide more combinations. For example, on two 
prescriptions that use circles in the pattern, one may have 
5 circles in a single unit of the repeating pattern, but 
the other may have 10, making the second composition much 
different in how compact the circles are and their size, 
instantly differentiating them. Similarly, squares can be 
rotated at 45 degrees to create a diamond shape. In 
combination to texture, what would originally be a 
perceptual sensation becomes physical as well. 
Textured patterns would be most helpful on cap design 
so as not to disrupt the important information on the 
label. It would also be more difficult to mass-manufacture 
a repeating pattern on a cylindrical surface as where a cap 
can be flat facing up in a 3D printing process. An example 
of this was conceptualized by two students, Ashley Ma and 
Alex Broerman at the University of Cincinnati in 2012.  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FIGURE 2. “INCLUSIVE PILL BOTTLES FOR THE BLIND” 
PACKAGING DESIGN SYSTEM CONCEPT BY ALEX BROERMAN 
AND ASHLEY MA AT THE UNIVERSITY OF CINCINNATI, 2012
IMAGE FROM MA’S PORTFOLIO SITE
Though this design has not been implemented by any major 
pharmacies or private merchants, the concept won the 
“Innov8 For Health,” competition sponsored by a variety of 
companies and institutions. They implemented eight unique 
textures for the top on a flip cap lid. It was important to 
note that not all visually impaired people read Braille, so 
they intended not to use this in the design system. Figure 
2 shows the CAD model of their concept, showing six of the 
eight designs, including a view of the cap opening. The 
colors are vibrant while also being different enough in 
brightness and contrast from the other. The pattern is 
large enough for tactile recognition for a patients figures 
to easily differentiate.
TYPOGRAPHY
Typography could serve as a third solution with 
changes to typeface, size, and hierarchy. The typeface 
design and size of the wording would be considered a visual 
enhancement while the treatment and hierarchy should be 
considered a textual enhancement. The two are different in 
that one pertains more to how the eye processes shape and 
the other relays and interprets messages. 
An example of visual enhancement is Maxular Rx, a 
typeface currently under development designed by Steve 
Skaggs at the University of Louisville. Maxular Rx is the 
first font ever to be produced specifically for people with 
macular degeneration. Macular degeneration affects central 
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vision, making crossing roads and reading difficult. 
Maxular employs the use of a bold stroke that is uniform in 
thickness in order to draw the eye to decipher parts of a 
letter which make it most recognizable. Additionally, 
avoiding sharp angles in the letterforms helps to avoid 
aggravated distortions associated with AMD. This typeface 
just finished clinical trials being tested against Times, 
Helvetica, Courier, and a new competing AMD typeface called 
Eido. So far, Maxular has performed well in the Reading 
Acuity (RA) test, the most valuable test point for a 
typeface to be used on a prescription label. Reading Acuity 
is the measurement of legibility at the smallest print size 
to be read. Critical Print Size (CPS) is the smallest print 
size for the best reading speed. Maximum Reading Speed is 
the measurement of time to speed read the text without the 
constraint of print size. These three categories of 
measurement are combined to create a MNRead test. This test 
showed that Maxular performed better than all other fonts 
in RA; in critical reading speed it was second to Courier. 
(Xiong, 2017). There was no significant benefit in the 
Maximum Reading Speed test. Maxular performed better than 
other typefaces due to the attention to the particular 
spacing between specific characters in a word, otherwise 
known as tracking. It also performed well due to generous 
x-height and ample line spacing.
Ligatures, or visually combined letters to create a 
single glyph, which is a single character, symbol, or 
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graphic used in word. Ligatures are carefully formulated 
for optimization between legibility and space. For example, 
the ligatures fi, ff, fl, and so on may connect at certain 
points that do not hinder the individual perception of a 
single letter. Figures 1 and 2 show examples of how some 
typefaces make a single glyph out of these letter 
combinations to the benefit or detriment of its legibility. 
Filson Soft and Myriad Pro are two san serif fonts that 
employ this strategy in different ways.
Word spacing breaks apart words and create negative 
space for the eye to rest and recognize the start of a new 
word. Maxular uses 150 units between words which helps as 
an extended typeface, helping to clearly separate words. 
This reduced crowding between words benefited Maxular in RA 
and CPS tests.  
"12
 "13
FIGURE 3. FILSON SOFT F-LIGATURES  
WITH OPTIMAL KERNING AND 0 TRACKING.
FIGURE 4. MYRIAD PRO F-LIGATURES  
WITH OPTIMAL KERNING AND 0 TRACKING.
An example of a textual enhancement using type would 
be Tall Man Lettering. A study at the University of 
Aberdeen sought to improve the relationship between 
proximity errors, time pressure, and a visual search of 
medication names (Irwin, 2012). The first thing to 
understand about the importance of readable and clear 
medication names is the history of why they look similar. 
Drug names that are visually similar have a characteristic 
called orthographic similarity. These visually similar 
words have nothing to do with the chemical make-up of the 
drugs, but rather the brand that created them. 
Understandably, this creates an adverse affect on 
recognition and memory.
Tall Man lettering was tested in this study to combat 
this effect, thus diminishing accidental medication mis-
adherence. Visually similar non-targets (medications NOT to 
be taken) and targets (prescribed medication) were placed 
together in a controlled space to simulate theories of 
visual search. Stimulus properties include the 
capitalization of a particular letter, initial, or 
combination of letters that differentiate the target from 
other non-targets, drawing attention to the relevant 
information on the label.
The claim was found to be false after a study with 
participants that were not pharmacists. Data collected 
indicated that Tall Man lettering was an insufficient form 
of textual enhancement for medication labeling, 
"14
particularly under time pressure. Reaction time and error 
rate were relatively unaffected (Irwin, 2012). Though the 
pharmacist population in this experiment indicated this 
claim as true, it could be that the frequency of medication 
dispensed by the pharmacists contributed to their success 
rate. It is understood that further studies may be 
necessary to prove the performance of Tall Man lettering. 
Further studies could include the use of phonetic emphasis 
on words instead. Focusing on how a word sounds may prove 
more user-oriented than how it looks, however pronunciation 
of a word can differ from user to user especially if the 
word has never been used or heard before.
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PHYSICAL IMPAIRMENT
Over 100 different types of arthritis affect 
approximately 30 million people in the United States 
according to the Georgia Tech Research Institute (2007). 
Other common physical disabilities that affect the ease of 
opening a prescription bottle include carpal tunnel, 
osteoporosis, and more generally hand dexterity limitations 
for 15.2 million Americans. 
The prevalence of these physical impairments indicates 
that there is a strong need for inclusion when 
manufacturing the standard bottle and cap design for their 
prescription. The bottles that are meant to hold the 
medications to soothe their symptoms are the same devices 
that are inhibiting the patient from taking them. 
The difficulty in opening the lids came from a need in 
the 70s and 80s for child resistant design and anti-
tampering. Though this is important, only recently have 
there been proposed solutions in cap designs for those with 
limited dexterity of the hands. The Arthritis Foundation is 
a nationally recognized entity that supports and educates 
Americans that are affected by all different types of 
arthritis and evaluates companies in relation to how they 
stand up to their standards. The Ease of Use Commendation 
comes from a test endorsed by the Arthritis Foundation and 
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conducted by the Intuitive Design Applied Research 
Institute (IDARI) who helps companies develop products for 
people with limitations like arthritis (arthritis.org). The 
first step of getting the Ease of Use Commendation is for a 
manufacturer to send their product design to the Arthritis 
Foundation for evaluation. From there, the product will go 
through a series of “pass/fail” tests conducted by 
scientists at IDARI. User tasks such as when the bottle is 
removed from its packaging, how it is opened, and how the 
pills are removed from the bottle are assessed and 
evaluated though multiple uses. After that, a group of 
eight research participants are chosen with the criterion 
of grip, torque, and muscle strength for moderate to severe 
arthritis. Muscle strength is further evaluated for 
endurance, pinch force and range of motion. So long as 
seven of the eight participants can successfully open the 
bottle without pain, the design is approved and rewarded 
the Ease of Use Commendation.   
The Aleve® Easy Open Soft Grip Arthritis Cap received 
the Ease of Use Commendation by the Arthritis Foundation. 
The cap is made of an easy-to-grip rubber-like material to 
provide traction for those that have arthritis. Though this 
medicine is not a prescription given by a pharmacist, the 
design could be implemented by manufacturers, such as 
Centor, that are used for that purpose.
The 1-Clic Packaging System by Centor also received an 
Ease of Use Commendation. The name 1-Clic comes from the a 
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audible “click” to indicate the closure has been secured 
correctly – a feature that encourages consistent and proper 
use. The closure is versatile with both child-resistant or 
non-child-resistant caps in the case that seniors and 
arthritic patients may have children around their medicine.
Although both of these products received the Ease of 
Use Commendation, they both require the patient to twist 
the cap or utilize their finger strength in some way. This 
is a pain point for most arthritis patients. Flip caps and 
push-to-open lids enable the patient to use other parts of 
their hand to open the bottle while still remaining child 
resistant. An example of this is shown in a conceptual 
design by Christine Chau. Her solution features a larger 
lid that can be opened in at least three ways: the side-
palm of the hand pushing sideways, the bottom-palm of the 
hand pushing up vertically, and gripping the lid and 
pulling up. This helps arthritic patients with limited 
dexterity in their fingers and more strength in the wrist. 
In addition, the bottle opening allows enough room for the 
patient to reach two fingers into the bottle rather than 
pouring the pills out onto the palm. Pouring the pills can 
result in the patients accidentally dropping them onto the 
ground or into a sink and down the drain, thus creating an 
inconvenience and strong pain point. Another example of a 
flip cap and push-to-open concept is the previously 
mentioned work of Broerman and Ma. Their design implemented 
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a simple button that can be pushed by thumb, finger, or 
palm in addition to the beneficial visual elements. 
Opening a bottle or compartment is just one stage of 
opening a prescription. For some, the opening of a bottle 
may be too narrow for thick fingers. Others, the size of 
the pill requires more dexterity or sensitively in the 
finger tips to grasp the bill within the hollow cylinder 
and pull or drag the pill out. Patients resort to pouring 
the medication into their hands or onto the counter, making 
the margin for error much greater with possibilities of 
spills.
There is potential now for automatic dispensers that 
implement voice control, proximity sensors, and biometric 
security. Speculatively speaking, sometime in the near 
future, there is a possibility that finger print sensors 
will be as common as they are a feature on our phones. 
Simple biometric algorithms could act not only as an 
unlocking feature to open a lid, but can also work as an 
identification feature for multi-person households and 
child-resistant packaging. Automatic dispensers are also 
closely related to multi-compartment medication devices, 
which are helpful for patients that also have early to 
middle stages of cognitive impairments. These devices will 






FIGURE 5. ALEVE® EASY OPEN 
SOFT GRIP ARTHRITIS CAP
IMAGE FROM ARTHRITIS.ORG




FIGURE 7. MEDICATION PACKAGING, 




The list of cognitive impairments is vast and 
complicated, and that is why this thesis focuses on groups 
of adults that are still able to perform activities of 
daily life, or ADLs. The majority of targeted studies use 
focus groups of adults 65 and older and use on average four 
medications chronically. As we age, the possibility of a 
memory or cognitive impairment increases. Types of 
cognitive impairment most commonly include mild cognitive 
impairments and types of dementia. 
Dementia with Lewy bodies, or  DLB, accounts for 10 to 
25% of dementia cases. Severity of confusion and alertness 
vary from day to day and may include changes in thinking 
and reasoning, visual hallucinations and delusions. Memory 
loss may be significant but its less prominent than in 
Alzheimers. Advanced DLB may cause memory problems in 
addition to its more typical effects on judgment, planning 
and visual perception. 
Compared to Alzheimers, movement symptoms are more 
likely to manifest early in DLB than in Alzheimer’s 
progresses to moderate and severe stages later. Up to 5% of 
the 5 million Americans with Alzheimers developed the the 
early-onset cognitive impairment before the age of 65. 
Early Alzheimers patients have trouble remembering recent 
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conversations and names or events, which can cause a 
serious mis-adherence in medication routines. Early on, 
individuals can use pill organizers, calendars, and other 
devices that can act as a reminder and prolong 
independence. Later stages of Alzheimers include impaired 
communication and difficulty speaking, which would make 
communication with a pharmacist or caregiver difficult. At 
that point in time, it is understood that variable required 
assistance will be needed to monitor and administer 
medication. 
There are two different mild cognitive impairments, or 
MCIs. Amnestic MCI patients forget information like 
appointments, conversations, and recent events that would 
otherwise be recalled easily. Non-amnestic MCIs have 
difficulty in judging time, sequence of steps in a complex 
task, making decisions, and visual perception. Non-amnestic 
MCIs would be more common in adults that exhibit mis-
adherence to medication routines. This can be supplemented 
with pill organizers, calendars and reminders.
If multiple medications have been prescribed for other 
serious health conditions, an organization system is 
essential to avoid missed or incorrect dosage that could 
lead to serious consequences (alz.org, 2017). A pill 
organizer depends on the patient to understand their 
medication direction from the pill bottle label and plan 
accordingly for the week ahead. For my grandmother, this is 
a problem as her mental health declines. My grandmother, 
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for example, may use a pill organizer but often forgets 
what day of the week it is. She believes she correctly took 
her Thursday medicine, but it is a Friday. This can 
seriously hurt her medication routine given that she may 
only take one medication every other day, but she 
accidentally ingests it two days in a row. For this reason, 
my mother is investing in a low grade multi-compartment 
medication device (MMD). From there, we will see if my 
grandmother is able to load her medication correctly 
herself. 
It is common that elderly patients may be taking more 
than four medications, so the use of a MMD would come in 
handy. MMDs have been evaluated in multiple studies from 
usability to emotional experiences related to them. In a 
study done in the UK on MMD ease of use, researchers found 
that the most valuable criterion for a successful MMD would 
exhibit readable text, easily opened compartments including 
removal, and the ability to transport the device. In this 
study, nearly all participants lived on their own at home 
with five as the median number of medications prescribed. 
Three major commercial MMDs were evaluated against each 
other and summarized by a formulated score. The three MMDs 
were the Venalink®, the Dossett®, and the Nomad Clear® and 




FIGURE 8. TABLE DATA AND IMAGES OF MMDS: THE 
DOSSETT, THE NOMAD CLEAR, AND THE VENALINK. 
FONT SIZES SUMMARIZED BELOW THEIR RESPECTIVE 
IMAGE.
TABLE AND IMAGES FROM ADAMS, 2013
The Venalink had reasonable text, but the reflective 
surface it was printed on took away from the clarity. 
Similarly, the Nomad and Venalink were agreed to have 
better visibility if printed on a different colored 
surface. Type size for the Nomad and Dossett were too 
small. The visual problems create complications before 
there is evidence of cognitive impairment.
Moreover, the most negatively reviewed MMD was the 
Vanalink because of ease of opening and removal of 
medication and was particularly worse with cognitively 
impaired patients. This study summarizes the main problem 
by claiming “healthcare professionals may need to be aware 
of such sensitivities when involving a patient in decision-
making” (Adams, 2013). User testing is paramount when 
creating devices that patients use so often their lives may 
depend on its success. 
Successful features can be seen in recent automatic 
dispensers. The MedReady by MedReady, Inc. incorporates a 
function that uses both a loud alarm as a reminder for up 
to four doses of medication per day. If the patient is hard 
of hearing or deaf, a bright red flashing light is an 
optional add on that will appear along with the alarm. The 
MedReady also uses a rechargeable battery that can generate 
power for 48 hours if unconnected from a power source in 
the event of traveling or a power outage.  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FIGURE 9. MEDREADY MMD BY MEDREADY, INC.
TOP-DOWN VIEW SHOWS THE PATIENT PERSPECTIVE, AN 
OPEN COMPARTMENT AND TIME DISPLAY ON LID.
IMAGE FROM MEDREADY, INC.
If the patient is still unable to adhere to the regimen, 
the MedReady sends a message to the MedReady, Inc. data 
centers to notify the caregiver via text message, email, or 
an automated phone call. Although this device is not a 
beautiful design, it appears as a device that is not to be 
tampered with. By hindering the patient from tampering, 
this keeps them honest to the routine and safe from 
overmedicating. The only way to open the compartment is to 
have a key that unlocks the lid, which reveals the 
compartments and the functional buttons that control the 
time display and alarm systems. Problems with this design 
is that each dose takes up would be a compartment for 
another day. In other words, if a patient takes medication 
at four different times in the day, then each day takes up 
four compartments, not one. This creates a problem with the 
frequency in which the MMD needs to be planned and 
refilled. This would require the patient to accurately 
refill themselves or call on a caregiver more often to 
organize the MMD, thus minimizing the independence the MMD 
is meant to provide the patient. 
There are more studies that need to be done on how the 
MMDs work for independent senior patients living at home. 
Adherence is directly dependent on not only memory or 
cognition of how, when, and where to take medication, but 
also on how the MMD is perceived such as how the text is 
read and how much the patient themselves can interact with 
the medication loading and dispensing (McGraw, 2004)  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THE SOLUTION
Systemic change is possible, but can be expensive. 
Preparation, marketing, and regulations will make any 
solution involving the pharmaceutical industry and 
government a difficult one. 
Manufacturers need to be prepared years in advance of 
release. Brand managers and product designers must 
communicate the color of medication class ahead of time so 
that they are prepared for what colors are used, the 
sequence, and the frequency of changes that will need to 
made during production. Multi-year stability experiments 
will need to take place to ensure the longevity and 
endurance of the solution. Stability testing is costly as 
well as the steps that precede it including, but not 
limited to, design, rapid prototyping, user testing, 
marketing and proposals. As mentioned before, IDARI offers 
ease of use testing, but a single design can cost upwards 
of $6,000. This may seem like a drop in the bucket for 
government spending, but there must be significant backing 
for a concept that will be released on a national scale and 
as eventual policy. After the product is released, there 
will more than likely be changes proposed, and system-wide 
modifications may be difficult to achieve. Safety and 
quality considerations must be balanced with cost 
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considerations, especially with concern to government if 
this is a product that will suggest a national standard 
with policy requirements. 
DESIGN
Summarizing the perceived successes and failures of 
the previously mentioned case studies, completion the ideal 
design will be a long road to pave. There may not be an 
answer for a singular design that is accessible and 
feasible for all, but there are design choices that can be 
addressed and implemented across the board. 
The ideal visual solution would use a typeface similar 
to Maxular Rx, perhaps a condensed version if possible. As 
for now, Maxular Rx is considered inefficient in terms of 
space and reading on a small surface. A condensed version 
would allow maximum readability at small sizes, even for 
those with signs of macular degeneration. Type size should 
generally not be smaller than 8 pt on a paper sticker label 
attached to a bottle, but should allow for efficient 
readability without turning the bottle. Color should be 
used in tandem with pattern, for quick identification and a 
failsafe for patients with color-blindness. Patterns that 
are able to be modeled into a 3D texture will further 
benefit patients that develop severely blurry or dark 
vision and are unable to read words or perceive shape and 
color. Speculative design thinking will lend itself to 
voice recordings that with the push of a button, voice what 
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medication it is, who it is intended for, how to take it, 
and if there are any messages such as if a refill is 
needed. 
The ideal physical solution would have a variety of 
options seeing as how arthritis can effect specific parts 
of the hands and wrist, each different. Combinations that 
allow the user to push a small button for a flip cap would 
be ideal, especially if the lid can close with a “click”, 
informing the user that the cap is correctly secured for 
storage. Upon opening the bottle or compartment holding the 
prescription, the user is allowed enough room to reach into 
and grab a single pill, no matter the size. Better yet, the 
patient is able to dispense only a single pill that is 
released directly into their palm. 
The ideal cognitive solution is multifaceted for 
reasons of convenience and severity of mental decline. Pill 
boxes, calendars, and organizers are not enough. MMDs are 
safe and efficient, but are unapproachable for the patient 
and do not have a friendly interface for the caregiver. An 
ideal MMD would have pill bottles dispense directly from 
the bottle, revealing the correct medication at the 
designated time and day. This would essentially eliminate 
“the middle man” that is specific to pill compartments. At 
the that the patient needs to take the prescription, the 
pill(s) would drop from the container(s) into a singular 
tray that is secured by the seniors biometric data (a 
fingerprint). The senior would hear a loud chiming sound, 
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notifying them that their prescription is ready. In 
addition, there are remote LEDs that can be placed around 
the living space that softly flash for a patient unable to 
hear. The senior that has a smart phone or tablet would 
also get a notification on their device notifying them of 
any important information. This UI would be reflected on 
the physical interface of the device, where they can see 
the name of the patient, the medication name, and any other 
notifications like if they need to re-fill their 
prescription. This option would allow the patient to 
automatically refill their prescription with the option of 
delivery to their home, and further assistance installing 
with the help of a pharmacy technician assistant. If an 
auto-refill is not approved, they have the option to video 
call their pharmacist, and leave a video message if there 
pharmacist is unable to answer. 
The patient could come back to their device at another 
time, and see if there is a notification from their 
pharmacist saying the auto-refill is approved or not. The 
dashboard where the patient receives these notifications 
would also provide general information, instructions, and 
warnings that are also available on the patient pamphlet 




Types of molds affect how cheap production would be 
for a systematic change for prescription bottle packaging 
design. This is a factor that could make or break the 
production of a solution, thus the knowledge of current 
manufacturing technology is helpful in pitching the 
concept.
Different manufacturing techniques include 
thermoforming, vacuum molds, extruded blow molding, and 
injection molds. Thermoforming is a manufacturing method 
that uses heat and pressure but can only be used to create 
solid or flat items. A functional derivative of this 
technique is vacuum molding. Vacuum molds work by heating a 
sheet of plastic to a forming temperature then stretching 
and forcing the material against the mold by a vacuum. 
These are usually used for protective coverings, but it is 
possible to create hollow shapes. An advantage of this 
method is that color changes are easy, but the simplicity 
of the shape made from this production technique is not 
right for prescription bottle or cap design at this time.
Another form of production is extruded blow molding. 
Fast production time makes for lower unit prices and 
tooling costs less than injection molding, but is still 
expensive. With extrusion blow molding, hollow parts are 
possible and there are a broad range of materials with the 
availability of different physical properties. This means 
that bottles are a possibility for both plastic and glass. 
The disadvantages are that both the tooling and machinery 
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are expensive, so there are large minimum orders. Long 
machine setups and production runs make color changes time 
consuming and expensive, thus extruded blow molding would 
not be the best route for a solution that relies on 
implementing bottle or cap color. In addition, the design 
is not as precise as injection molding, which would prevent 
the use of textural patterns for those with visual 
impairment.
Injection molding is the best solution for production. 
Injection molds work by using high pressure conditions and 
using heat softened materials (Zema, 2012). The material is 
shaped in a mold cavity that provides the most intricacy of 
any of the previously listed production methods. There is 
no need for water or solvents, making production cheaper. 
Continuous manufacturing makes production faster and more 
efficient, adding to the products scalability. The 
precision of the mold allows for versatility in design, 
making the use of pattern and texture feasible in the 
design. In regards to 3D printing, where rapid prototyping 
and intricate forms can be tested, the two complement each 
other in production. In this case, a cap or bottle can be 
used in user testing before ever hitting the market and if 
testing is successful, mass production can roll forward 
with injection molding. In mass quantity, a new design can 
be presented as low cost for the manufacturer and high 
quality for the patient.
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A user interface that is constructed with an MMD would 
take years to execute in both terms of design, research, 
physical manufacturing, and software engineering. Existing 
technology may be obsolete by the time this is released, 
but transitional technology available now such as RFID 
tags, NFC chips, and biometric scanners are small enough to 
implement in so many different iterations. It is difficult 
to speculate what this product would look like, but further 
exploration would be beneficial in partnership with 
industrial designers, user experience designers, user 
interface designers, and service designers. 
CONCLUSION
This thesis was meant to bring to attention the 
current stage of prescription design for the impaired and 
offer speculative design suggestions that may benefit both 
the patient and the healthcare industry as a whole. Medical 
mis-adherence is a serious problem that can be solved with 
the use of empathetic human-centered design, careful 
planning, and acceptance from the parties that control what 
is standard. With the possibilities that technology offers 
today, there are endless solutions waiting to be explored.  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